ALK and inflammatory myofibroblastic tumor: TPM3-ALK and TPM4-ALK, a fusion protein consisting of the N-terminal of TPM and the C-terminal kinase domain of ALK, have been reported in patients with inflammatory myofibroblastic tumors, with TPM3-ALK being the most commonly observed [54].